Research progress on clinical intervention of depression in cancer patients undergoing chemotherapy

Abstract

Abstract:

Patients undergoing cancer chemotherapy are most likely to be associated with depression. Depression can affect the efficacy of chemotherapy drugs and increase the adverse reaction. This article reviews the current status of clinical intervention of cancer chemotherapy in patients with depression, focusing on psychological intervention to improve the research progress of depression in cancer patients undergoing chemotherapy and the matters needing attention on intervention process, and to provide the basis for clinical practice.

Key words: cancer chemotherapy patients, depression, clinical intervention

CLC Number:

R749
R730

LI Xiu, JI Zhaoning. Research progress on clinical intervention of depression in cancer patients undergoing chemotherapy[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 110-114.

References

［1］沈渔邨. 精神病学［M］. 4版，北京: 人民卫生出版社，2002: 6.
［2］徐光炜. 临床肿瘤学［M］. 沈阳：辽宁教育出版社，2000，381-397.
［3］Wedding U, Koch A, Sauer H, et al. Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy［J］. Acta Oncol，2008，47（1）：56-62.
［4］贺亚丽. 癌症化疗患者心理障碍原因分析和护理［J］. 美国中华临床医学杂志, 2004，6(4): 3521-3525.
［5］吴美华，吴艳云，陈秀英, 等. 癌症化疗患者抑郁状态的相关因素调查与护理对策［J］.福建医药杂志，2004，26（6）：201-202.
［6］Spoletini I，Gianni W，Repetto L，et al. Depression and cancer: anunexplored and unresolved emergent issue in elderly patients［J］. Crit Rev Oncol Hematol，2008，65(2): 143-155.
［7］王雪. 抗抑郁治疗的临床现状［J］.中国慢性病预防与控制，2009，17(2): 218 -220.
［8］徐光炜（主译）. 临床肿瘤学［M］. 沈阳：辽宁教育出版社，2000，381-397.
［9］蒋有倩. 中医辨证分型治疗例抑郁综合征［J］.上海中医药杂志，1999,（5）：20.
［10］徐薇，秦竹，熊洪艳, 等. 中医方剂治疗抑郁症浅析［J］.云南中医中药杂志，2008, 29（7）：6.
［11］刘晓平. 常用单味中药提取物抗抑郁研究文献调查［J］. 中国中医药杂志，2010, 8（18）: 246.
［12］秦凤展，陈振东，樊青霞, 等. 肿瘤内科治疗［M］. 北京：人民军医出版社，2004，389-397.
［13］郝建波. 肿瘤术后化疗患者的抑郁情绪现状及心理干预研究［D］. 2012，青岛大学.
［14］张曼华. 肿瘤患者心理干预研究的现状［J］.中国行为医学科学，2005，14(6): 487-489.
［15］姜乾金. 医学心理学［M］. 4版，北京：人民卫生出版社，2008，20 -22.
［16］陈维萍, 童建冲, 屠萌君, 等. 认知行为干预对肿瘤病人化疗间歇期生活质量的影响［J］. 护理研究，2007，21(8): 2214-2215.
［17］赵江, 王维利, 宋江艳, 等. 肿瘤术后化疗病人自动思维与抑郁情绪相关性研究［J］.护理研究，2011, 25(8): 2547-2550.
［18］宋江艳. 肿瘤术后化疗患者抑郁情绪现状及其治疗性沟通系统干预效果研究［D］. 2010，安徽医科大学.
［19］Vnden BM,Visser A.Evaluation of haptotherapy for patients with cancer treated with chemotherapy at a day clinic［J］.Patient Educ Couns,2006,60(3): 336-343.
［20］王亚朋，庞英，唐丽丽, 等. 团体心理治疗对胃癌患者生活质量及情绪状况的效果［J］.中国心理卫生杂志，2013，27 ( 7) :490-495.
［21］齐彦春．音乐疗法的相关问题及其临床应用［J］. 护理研究，2004，18（3B）：473-474.
［22］谢忠，黄钢，银正民, 等. 音乐治疗加放松内心意象法对癌症化疗病人生活质量的影响［J］. 中国心理卫生杂志，2001，15(2):176-178.
［23］胡淑贤，石搏，黄可欣. 不同类型音乐对缓解乳腺癌患者化疗焦虑、抑郁的效果研究［J］.中国妇幼保健，2013，28(2):359-361.
［24］汪敏，陈芬，姜梦媛. 中医音乐对焦虑抑郁型肺癌病人化疗期间生活质量影响的研究［J］.护理研究，2011，25(27):2478-2479.
［25］李钢，尹剑春. 太极拳运动对女大学生心境以及安静状态下β内啡肽的影响［J］. 北京体育大学学报，2008，31(3):356-358.
［26］王洪志. 中医心理治疗理念简述［J］.中国心理卫生杂志，2015，29(10):729-732.
［27］王晓秋，林长虹，刘佰杰. 冥想在癌症患者抑郁症中的应用［J］.吉林医学，2013，34(22):4596-4597.
［28］Shapiro SL, Carlson LE, Astin JA, et al. Mechanisms of mindfulness［J］. J Clin Psychol, 2006，62 (3)：373-386.
［29］任俊，黄璐，张振新. 基于心理学视域的冥想研究［J］. 心理学探新，2010，18 (5): 857-864.
［30］Baer RA. Mindfulness training as a clinical intervention: A conceptual and empirical review［J］.Clin Psychol Sci Prac, 2003, 10 (2):125-143.
［31］Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness［J］. Neuroreport, 2005, 16(17):1893-1897.
［32］Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients［J］. Int J Behav Med, 2005, 12(4): 278-285.

[1]	ZHANG Taotao, SU Wenxiu, TIAN Limin. Research progress on the relationship between subclinical hypothyroidism and depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 954-960.
[2]	HE Teng, XU Xiangyang, XU Xiangqing, LIU Cunming, YANG Chun. Ketamine for depression treatment: past, present, and future [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1125-1132.
[3]	WANG Yeqing, WANG Yuhong, LIU Jian, ZHAO Hongqing, ZOU Manshu. Research progress of relevance between cholecystokinin and depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 672-679.
[4]	CHEN Ying, YUAN Yonggui. Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
[5]	YANG Shitao, ZHU Yihong, TANG Wenxin. Effects of aripiprazole combined with duloxetine on the treatment effect and VEGF level in patients with refractory depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 937-942.
[6]	GE Wei, SHENG Wenyan, XU Qibing, LI Qiushi, SU Lingya, WU Shuangqing. Effects of SSRI antidepressant sertraline on ocular surface function in patients with postpartum depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 440-446.
[7]	FENG Rui, ZHANG Jiali, HE Mingchao, LI Yue, ZHANG Yan. Pharmacological targets and clinical application of traditional Chinese medicine and active components in the prevention and treatment for depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 467-474.
[8]	WANG Sijie，ZHANG Jun，LI Qian，HUANG Hua，WANG Jingjing，ZHOU Qiong，YAO Qin. Research progress on the safety and effectiveness of escitalopram in the treatment of pregnant women with depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1070-1074.
[9]	ZHOU Yancan. Effects of agomelatine on depressive disorder and brain-derived neurotrophic factor ZHOU Yancan [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 699-703.
[10]	CHEN Lianzhou, LI Songhua, PU Ben. Effects of aripiprazole combined with escitalopram oxalate on DA, 5-HT and cortisol in patients with severe depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 446-450.
[11]	CAI Dandan, GUI Donghui, ZHANG Jianbing, ZHOU Wenhua. Clinical efficacy of low dose risperidone combined with trazodone in the treatment of heroin addicts during detoxification [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 94-98.
[12]	WANG Rouxin, FANG Zekang, YAO Siqi, XUE Yingying, ZHAO Yeying, YE Yilu. Effects of nicotinamide ribose on adolescent depression rats after neonatal maternal deprivation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1015-1021.
[13]	WU Mengyao, ZHAO Hongqing, WANG Yuhong. Advances of the ion channels related to depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 949-954.
[14]	ZHOU Rong, LI Wei, HU Wanhua. Effects of Yinaojieyu prescription on the kidney deficiency and liver depression of Parkinson's disease and the effect on DA, 5-HT and NE in serum [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 434-439.
[15]	ZHOU Yancan, PING Jing, SHAN Jianmin. Effects of Wuling capsule combined with agomelatin in female patients with depression and sleep disorders and its effect on neurotransmitters and endocrine hormones [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1415-1419.